"
Team:Potsdam Bioware
From 2012.igem.org
(→Project Description) |
(→Direct Antibody Identification, Maturation and Production in CHO-Cells) |
||
| Line 68: | Line 68: | ||
<head> | <head> | ||
<style type="text/css"> | <style type="text/css"> | ||
| + | |||
| + | body { | ||
| + | |||
| + | background: rgb(255,255,255); | ||
| + | background: -moz-linear-gradient(top, rgba(255,255,255,1) 16%, rgba(153,153,153,1) 100%); | ||
| + | background: -webkit-gradient(linear, left top, left bottom, color-stop(16%,rgba(255,255,255,1)), color-stop(100%,rgb(153,153,153,1))); | ||
| + | background: -webkit-linear-gradient(top, rgba(255,255,255,1) 16%,rgba(153,153,153,1) 100%); | ||
| + | background: -o-linear-gradient(top, rgba(255,255,255,1) 16%,rgba(153,153,153,1) 100%); | ||
| + | background: -ms-linear-gradient(top, rgba(255,255,255,1) 16%,rgba(153,153,153,1) 100%); | ||
| + | background: linear-gradient(to bottom, rgba(255,255,255,1) 16%,rgba(153,153,153,1) 100%); | ||
| + | filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ffffff', endColorstr='#999999',GradientType=0 ); | ||
| + | |||
| + | } | ||
| + | |||
.box_round { | .box_round { | ||
Revision as of 20:38, 24 August 2012
Direct Antibody Identification, Maturation and Production in CHO-Cells
Project Description
Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|